Literature DB >> 21050055

Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: a study from Bikaner (Northwestern India).

Dhanpat Kumar Kochar1, Ashis Das, Abhishek Kochar, Sheetal Middha, Jyoti Acharya, Gajanand Singh Tanwar, Anjana Gupta, Deepak Pakalapati, Shilpi Garg, Vishal Saxena, Amit Kumar Subudhi, P A Boopathi, Parmendra Sirohi, Sanjay Kumar Kochar.   

Abstract

The occurrence, relation and magnitude of thrombocytopenia in different species of malaria are not clearly defined. This study included 1,064 patients admitted with malaria to study thrombocytopenia (platelet count <150,000 /cumm) in Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) mono infection and mixed infection (Pf + Pv). The species diagnosis was done by peripheral blood film (PBF) and rapid diagnostic test (RDT). Validation by polymerase chain reaction (PCR) was done only in patients with severe thrombocytopenia (platelet count <20,000 /cumm). The breakup of patients was 525 (49.34%) Pf, 460 (43.23%) Pv and 79 (7.42%) mixed malaria (Pf + Pv). Thrombocytopenia was observed in 24.6% (262/1064) patients. The risk was greatest in the mixed infections in comparison to monoinfection individually (43.04% [34/79]; mixed vs Pv monoinfection: Odds Ratio [OR] = 1.675 [95% Confidence Interval (CI) 1.029-2.726], p < 0.0366; mixed vs Pf monoinfection: OR=3.911 [95% CI 2.367-6.463], p < 0.0001). Pv monoinfection (31.09% [143/460]) had greater risk compared to Pf monoinfection (16.19% [85/525]; OR = 2.335 [95% CI 1.722-3.167], p < 0.0001). The occurrence of severe thrombocytopenia was also higher in Pv monoinfection (18.18% [26/143]) in comparison to either Pf monoinfection (10.59% [9/85], OR = 1.877 (95% CI 0.834-4.223)) or mixed infection (11.76% [4/34]; OR = 1.667 (95% CI 0.540-5.142) but this association was statistically not significant. Six patients (3 Pv, 2 Pf and 1 mixed) developed severe epistaxis requiring platelet transfusion. There was no relation between parasite density and platelet count as many patients with severe thrombocytopenia had parasite density similar to patients without thrombocytopenia. We found that the association of thrombocytopenia was statistically more significant with P. vivax monoinfection as compared to P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050055     DOI: 10.3109/09537104.2010.505308

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  32 in total

1.  Renal cortical necrosis and acute kidney injury associated with Plasmodium vivax: a neglected human malaria parasite.

Authors:  Vivek B Kute; Aruna V Vanikar; Pramod P Ghuge; Jitendra G Goswami; Mohan P Patel; Himanshu V Patel; Manoj R Gumber; Pankaj R Shah; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2012-06-06       Impact factor: 2.289

Review 2.  Malaria evolution in South Asia: knowledge for control and elimination.

Authors:  Krishnamoorthy Narayanasamy; Laura Chery; Analabha Basu; Manoj T Duraisingh; Ananias Escalante; Joseph Fowble; Jennifer L Guler; Thurston Herricks; Ashwani Kumar; Partha Majumder; Jennifer Maki; Anjali Mascarenhas; Janneth Rodrigues; Bikram Roy; Somdutta Sen; Jayanthi Shastri; Joseph Smith; Neena Valecha; John White; Pradipsinh K Rathod
Journal:  Acta Trop       Date:  2012-01-14       Impact factor: 3.112

3.  Unusual presentation of Plasmodium vivax: a neglected human malaria parasite.

Authors:  Vivek B Kute; Jitendra G Goswami; Aruna V Vanikar; Pankaj R Shah; Manoj R Gumber; Himanshu V Patel; Kamal V Kanodia; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

4.  Malaria in selected non-Amazonian countries of Latin America.

Authors:  Myriam Arevalo-Herrera; Martha Lucia Quiñones; Carlos Guerra; Nora Céspedes; Sandra Giron; Martha Ahumada; Juan Gabriel Piñeros; Norma Padilla; Zilka Terrientes; Angel Rosas; Julio Cesar Padilla; Ananias A Escalante; John C Beier; Socrates Herrera
Journal:  Acta Trop       Date:  2011-07-01       Impact factor: 3.112

5.  Diagnostic Value of Platelet and Leukocyte Counts in the Differential Diagnosis of Fever in the Returning Traveler.

Authors:  Elisa Rubio; Izaskun Alejo-Cancho; Cristian Aylagas; Daniel Camprubí; Roser Ferré; Ma Rosa Albarracín; Verónica Gonzalo; Josep Barrachina; Míriam José Álvarez-Martínez; Maria Eugenia Valls; Jordi Mas; Jordi Vila; Irene Losada; Miguel J Martínez; Climent Casals-Pascual
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

6.  Influence of Plasmodium vivax malaria on the relations between the osmotic stability of human erythrocyte membrane and hematological and biochemical variables.

Authors:  Rita de Cássia Mascarenhas Netto; Camila Fabbri; Mariana Vaini de Freitas; Morun Bernardino Neto; Mário Silva Garrote-Filho; Marcus Vinícius Guimarães Lacerda; Emerson Silva Lima; Nilson Penha-Silva
Journal:  Parasitol Res       Date:  2013-12-10       Impact factor: 2.289

7.  Thrombocytopenia in children with vivax malaria: a study from north India.

Authors:  Chandra Mohan Kumar; Shweta Singh; Rajnish Garg
Journal:  Indian J Pediatr       Date:  2013-12-11       Impact factor: 1.967

8.  Development and evaluation of a 28S rRNA gene-based nested PCR assay for P. falciparum and P. vivax.

Authors:  Deepak Pakalapati; Shilpi Garg; Sheetal Middha; Jyoti Acharya; Amit K Subudhi; Arunachalam P Boopathi; Vishal Saxena; Sanjay K Kochar; Dhanpat K Kochar; Ashis Das
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

Review 9.  Malaria diagnostics in clinical trials.

Authors:  Sean C Murphy; Joseph P Shott; Sunil Parikh; Paige Etter; William R Prescott; V Ann Stewart
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

10.  Total parasite biomass but not peripheral parasitaemia is associated with endothelial and haematological perturbations in Plasmodium vivax patients.

Authors:  João L Silva-Filho; João Ck Dos-Santos; Carla Judice; Dario Beraldi; Kannan Venugopal; Diogenes Lima; Helder I Nakaya; Erich V De Paula; Stefanie Cp Lopes; Marcus Vg Lacerda; Matthias Marti; Fabio Tm Costa
Journal:  Elife       Date:  2021-09-29       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.